查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1842391

全球临床前CRO市场：市场规模、份额和趋势分析（按服务、模型类型、最终用途和地区划分），细分市场预测（2025-2033年）

Preclinical CRO Market Size, Share & Trends Analysis Report By Service (Toxicology Testing, Bioanalysis & DMPK Studies, Chemistry), By Model Type, By End-use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

临床前CRO市场摘要

全球临床前 CRO 市场预计在 2024 年达到 61.9 亿美元，预计到 2033 年将达到 123.7 亿美元，2025 年至 2033 年的复合年增长率为 8.03%。

市场成长的驱动因素包括研发投资激增、药物开发日益复杂化以及对专业化和先进治疗方法的需求转变。

推动该市场发展的主要因素是药物研发的日益复杂化和内部研发基础设施的高昂成本，这导致临床前CRO服务的使用率不断提高。药物研发企业将毒理学、药理学和生物分析等研究外包给专业服务供应商，以加快产品上市速度并控制营运风险。慢性病和复杂疾病的普遍存在进一步加剧了这一趋势，因为这些疾病需要更广泛的临床前评估。此外，外包还使资源有限的小型生技公司能够获得先进技术和全球专业知识，而无需建立庞大的内部团队。

目录

第一章 分析方法和范围

第二章执行摘要

第三章：临床前CRO市场：驱动因素、趋势与范围

  • 市场关联性展望
  • 临床前CRO市场动态
  • 技术格局
  • 定价模式分析
  • 临床前CRO市场：分析工具

第四章 临床前CRO市场：按服务分類的估算与趋势分析

  • 细分仪表板
  • 全球临床前CRO市场：按服务类型分類的差异分析
  • 全球临床前CRO市场规模及服务趋势分析（2021-2033年）
  • 生物分析和DMPK研究
    • 体外ADME
    • 体内药物动力学
  • 毒性测试
    • GLP
    • 非GLP规范
  • 化合物管理
    • 製程研究与开发
    • 客製合成
    • 其他的
  • 化学
    • 药物化学
    • 计算化学
  • 安全药理学
  • 其他的

第五章 临床前CRO市场：依模式类型分類的估算与趋势分析

  • 细分仪表板
  • 全球临床前CRO市场：按模式类型分類的差异分析
  • 全球临床前CRO市场规模及趋势分析（依模式类型划分）（2021-2033年）
  • 患者来源的类器官（PDO）模型
  • 患者来源的异种移植（PDX）模型

第六章：临床前CRO市场：依最终用途分類的估算与趋势分析

  • 细分仪表板
  • 全球临床前CRO市场：依最终用途分類的差异分析
  • 全球临床前CRO市场规模及趋势分析（依最终用途划分）（2021-2033年）
  • 生物製药公司
  • 政府和学术机构
  • 医疗设备公司

7. 临床前CRO市场：区域估算和趋势分析（按服务、模型类型和最终用途划分）

  • 市场概览：按地区
  • 全球市场概览：按地区划分
  • 市场规模预测及趋势分析（2021-2033）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特
    • 阿曼
    • 卡达

第八章 竞争情势

  • 公司分类
  • 临床前CRO市占率分析（2024年）
  • 公司简介
    • Eurofins Scientific
    • PRA Health Sciences, Inc.
    • Wuxi AppTec
    • Medpace, Inc.
    • Charles River Laboratories International, Inc.
    • PPD Thermo Fisher Scientific, Inc.
    • SGA SA
    • Intertek Group Plc（IGP）
    • LABCORP
    • Crown Bioscience
Product Code: GVR-2-68038-035-4

Preclinical CRO Market Summary

The global preclinical CRO market size was estimated at USD 6.19 billion in 2024 and is projected to reach USD 12.37 billion by 2033, growing at a CAGR of 8.03% from 2025 to 2033. The market is driven escalating R&D investments, the growing complexity of drug development, and the shifting demand toward specialized and advanced therapeutic modalities.

The market is primarily driven by the increasing complexity of drug discovery, along with the high costs of in-house research infrastructure, is driving greater adoption of preclinical CRO services. Drug developers are outsourcing studies such as toxicology, pharmacology, and bioanalysis to specialized service providers to reduce time-to-market and manage operational risks. This trend is further amplified by the growing prevalence of chronic and complex diseases, which require more extensive preclinical evaluations. Outsourcing also enables smaller biotech firms, which often have limited resources, to access advanced technologies and global expertise without the need for large-scale internal setups.

Global Preclinical CRO Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global preclinical CRO market report based on service, model type, end-use, and region:

  • Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Bioanalysis and DMPK studies
    • In vitro ADME
    • In-vivo PK
  • Toxicology Testing
    • GLP
    • Non-GLP
  • Compound Management
    • Process R&D
    • Custom Synthesis
    • Others
  • Chemistry
    • Medicinal Chemistry
    • Computation Chemistry
  • Safety Pharmacology
  • Others
  • Model Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Patient Derived Organoid (PDO) Model
  • Patient derived xenograft model
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Biopharmaceutical Companies
  • Government and Academic Institutes
  • Medical Device Companies
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Norway
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
    • Oman
    • Qatar

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Value chain based analysis (Model 2)
    • 1.7.3. Multivariate Analysis (Model 3)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Preclinical CRO Market: Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Preclinical CRO Market Dynamics
    • 3.2.1. Market Driver Impact Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Technological Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Preclinical CRO Market: Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. PESTEL Analysis

Chapter 4. Preclinical CRO Market: Service Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Preclinical CRO Market Service Movement Analysis
  • 4.3. Global Preclinical CRO Market Size & Trend Analysis, by Service, 2021 to 2033 (USD Million)
  • 4.4. Bioanalysis and DMPK Studies
    • 4.4.1. Bioanalysis and DMPK Studies Market Estimates and Forecasts, 2021 - 2033 (USD million)
    • 4.4.2. In vitro ADME
      • 4.4.2.1. In vitro ADME Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. In-vivo PK
      • 4.4.3.1. In-vivo PK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Toxicology Testing
    • 4.5.1. Toxicology Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. GLP
      • 4.5.2.1. GLP Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Non-GLP
      • 4.5.3.1. Non-GLP Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Compound Management
    • 4.6.1. Compound Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.2. Process R&D
      • 4.6.2.1. Process R&D Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.3. Custom Synthesis
      • 4.6.3.1. Custom Synthesis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.4. Others
      • 4.6.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Chemistry
    • 4.7.1. Chemistry Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7.2. Medicinal Chemistry
      • 4.7.2.1. Medicinal Chemistry Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7.3. Computation Chemistry
      • 4.7.3.1. Computation Chemistry Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Safety Pharmacology
    • 4.8.1. Safety Pharmacology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9. Others
    • 4.9.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Preclinical CRO Market: Model Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Preclinical CRO Market Model type Movement Analysis
  • 5.3. Global Preclinical CRO Market Size & Trend Analysis, by Model type, 2021 to 2033 (USD Million)
  • 5.4. Patient Derived Organoid (PDOs) Models
    • 5.4.1. Patient Derived Organoid (PDOs) Models Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Patient Derived Xenograft (PDX) Models
    • 5.5.1. Patient Derived Xenograft (PDX) Models Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Preclinical CRO Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Preclinical CRO Market End Use Movement Analysis
  • 6.3. Global Preclinical CRO Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Biopharmaceutical Companies
    • 6.4.1. Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Government and Academic Institutes
    • 6.5.1. Government and Academic Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Medical Device Companies
    • 6.6.1. Medical Device Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Preclinical CRO Market: Regional Estimates & Trend Analysis by Service, Model Type, End Use

  • 7.1. Regional Market Dashboard
  • 7.2. Global Regional Market Snapshot
  • 7.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.6. Oman
      • 7.8.6.1. Key Country Dynamics
      • 7.8.6.2. Competitive Scenario
      • 7.8.6.3. Regulatory Framework
      • 7.8.6.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.7. Qatar
      • 7.8.7.1. Key Country Dynamics
      • 7.8.7.2. Competitive Scenario
      • 7.8.7.3. Regulatory Framework
      • 7.8.7.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Preclinical CRO Market Share Analysis, 2024
  • 8.3. Company Profiles
    • 8.3.1. Eurofins Scientific
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. PRA Health Sciences, Inc.
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Wuxi AppTec
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Medpace, Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Charles River Laboratories International, Inc.
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. PPD Thermo Fisher Scientific, Inc.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. SGA SA
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Intertek Group Plc (IGP)
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. LABCORP
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Crown Bioscience
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Preclinical CRO market estimates and forecasts, by region, 2021 - 2033 (USD Million)
  • Table 3 North America Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million)
  • Table 4 North America Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million)
  • Table 5 North America Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 6 U.S. Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million)
  • Table 7 U.S. Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million)
  • Table 8 U.S. Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 9 Canada Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million)
  • Table 10 Canada Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million)
  • Table 11 Canada Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 12 Mexico Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million)
  • Table 13 Mexico Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million)
  • Table 14 Mexico Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 15 Europe Preclinical CRO market estimates and forecasts, by region, 2021 - 2033 (USD Million)
  • Table 16 Europe Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million)
  • Table 17 Europe Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million)
  • Table 18 Europe Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 19 UK Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million)
  • Table 20 UK Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million)
  • Table 21 UK Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 22 Germany Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million)
  • Table 23 Germany Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million)
  • Table 24 Germany Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 25 France Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million)
  • Table 26 France Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million)
  • Table 27 France Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 28 Italy Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million)
  • Table 29 Italy Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million)
  • Table 30 Italy Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 31 Spain Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million)
  • Table 32 Spain Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million)
  • Table 33 Spain Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 34 Norway Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million)
  • Table 35 Norway Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million)
  • Table 36 Norway Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 37 Denmark Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million)
  • Table 38 Denmark Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million)
  • Table 39 Denmark Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 40 Sweden Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million)
  • Table 41 Sweden Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million)
  • Table 42 Sweden Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 43 Asia Pacific Preclinical CRO market estimates and forecasts, by region, 2021 - 2033 (USD Million)
  • Table 44 Asia Pacific Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 47 Japan Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million)
  • Table 48 Japan Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million)
  • Table 49 Japan Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 50 China Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million)
  • Table 51 China Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million)
  • Table 52 China Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 53 India Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million)
  • Table 54 India Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million)
  • Table 55 India Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 56 Australia Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million)
  • Table 57 Australia Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million)
  • Table 58 Australia Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 59 South Korea Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million)
  • Table 60 South Korea Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million)
  • Table 61 South Korea Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 62 Thailand Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million)
  • Table 63 Thailand Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million)
  • Table 64 Thailand Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 65 Latin America Preclinical CRO market estimates and forecasts, by region, 2021 - 2033 (USD Million)
  • Table 66 Latin America Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million)
  • Table 67 Latin America Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million)
  • Table 68 Latin America Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 69 Brazil Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million)
  • Table 70 Brazil Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million)
  • Table 71 Brazil Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 72 Argentina Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million)
  • Table 73 Argentina Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million)
  • Table 74 Argentina Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 75 MEA Preclinical CRO market estimates and forecasts, by region, 2021 - 2033 (USD Million)
  • Table 76 MEA Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million)
  • Table 77 MEA Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million)
  • Table 78 MEA Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 79 South Africa Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million)
  • Table 80 South Africa Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million)
  • Table 81 South Africa Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 82 Saudi Arabia Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million)
  • Table 83 Saudi Arabia Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million)
  • Table 84 Saudi Arabia Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 85 Kuwait Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million)
  • Table 86 Kuwait Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million)
  • Table 87 Kuwait Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 88 UAE Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million)
  • Table 89 UAE Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million)
  • Table 90 UAE Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 91 Oman Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million)
  • Table 92 Oman Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million)
  • Table 93 Oman Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 94 Qatar Preclinical CRO market estimates and forecasts, by service, 2021 - 2033 (USD Million)
  • Table 95 Qatar Preclinical CRO market estimates and forecasts, by model type, 2021 - 2033 (USD Million)
  • Table 96 Qatar Preclinical CRO market estimates and forecasts, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Preclinical CRO market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Value-Chain-Based Sizing & Forecasting
  • Fig. 9 QFD model sizing & forecasting
  • Fig. 10 Bottom-up approach
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Segment snapshot
  • Fig. 14 Segment snapshot
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Parent market outlook, 2024 (USD Million)
  • Fig. 17 Ancillary market outlook, 2024 (USD Million)
  • Fig. 18 Preclinical CRO market dynamics
  • Fig. 19 Total R&D drug pipeline size, 2021-2024
  • Fig. 20 Total drug pipeline by development phase, 2024
  • Fig. 21 Porter's five forces analysis
  • Fig. 22 PESTEL analysis
  • Fig. 23 Preclinical CRO market Service outlook: Segment dashboard
  • Fig. 24 Preclinical CRO market, by Service segment: Market share, 2025 & 2033
  • Fig. 25 Bioanalysis and DMPK Studies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 In vitro ADME market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 In-vivo PK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Toxicology Testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 GLP market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Non-GLP market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Compound Management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Process R&D market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Custom Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Chemistry market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Medicinal Chemistry market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Computation Chemistry market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Preclinical CRO market Model type outlook: Segment dashboard
  • Fig. 39 Preclinical CRO market, by Model type segment: Market share, 2025 & 2033
  • Fig. 40 Patient Derived Organoid (PDOs) Models market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Patient Derived Xenograft (PDX) Models market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Preclinical CRO market End Use outlook: Segment dashboard
  • Fig. 43 Preclinical CRO market, by End Use segment: Market share, 2025 & 2033
  • Fig. 44 Biopharmaceutical Companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Government and Academic Institutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Medical Device Companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Regional market: Key takeaways
  • Fig. 48 Regional marketplace: Key takeaways
  • Fig. 49 North America Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 U S Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Canada Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Mexico Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Europe Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 UK Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Germany Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 France Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Italy Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Spain Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Denmark Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Norway Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Sweden Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Asia Pacific Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Japan Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 China Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 India Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Australia Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 South Korea Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Thailand Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 86 Latin America Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Brazil Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Argentina Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 91 MEA Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 South Africa Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Saudi Arabia Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 Kuwait Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 UAE Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 100 Key country dynamics
  • Fig. 101 Oman Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 102 Key country dynamics
  • Fig. 103 Qatar Preclinical CRO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 104 Market participant categorization
  • Fig. 105 Heat map analysis